For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
The price of BioRestorative Therapies Inc (NASDAQ: BRTX) closed at $1.82 in the last session, up 13.75% from day before closing price of $1.60. In other words, the price has increased by $13.75 from its previous closing price. On the day, 2.5 million shares were traded.
Ratios:
We take a closer look at BRTX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.94 and its Current Ratio is at 2.94. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Oct 28 ’24 when Broadrick Dale sold 1,112 shares for $1.58 per share. The transaction valued at 1,757 led to the insider holds 445,933 shares of the business.
Silva Francisco bought 6,600 shares of BRTX for $8,250 on Apr 09 ’24. The VP of Research and Development now owns 155,759 shares after completing the transaction at $1.25 per share. On Apr 08 ’24, another insider, Silva Francisco, who serves as the VP of Research and Development of the company, bought 1,708 shares for $1.16 each. As a result, the insider paid 1,979 and bolstered with 149,159 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 33.14 while its Price-to-Book (P/B) ratio in mrq is 1.26.
Stock Price History:
Over the past 52 weeks, BRTX has reached a high of $2.55, while it has fallen to a 52-week low of $1.03. The 50-Day Moving Average of the stock is -4.72%, while the 200-Day Moving Average is calculated to be 9.14%.
Shares Statistics:
A total of 6.92M shares are outstanding, with a floating share count of 5.02M. Insiders hold about 27.48% of the company’s shares, while institutions hold 13.94% stake in the company.
